Literature DB >> 35422623

Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study.

Atsuko Ikenouchi1,2, Yusuke Konno1,3, Yoshihisa Fujino3, Naoto Adachi4, Yukihisa Kubota4, Takaharu Azekawa4, Hitoshi Ueda4, Koji Edagawa4, Eiichi Katsumoto4, Eiichiro Goto4, Seiji Hongo4, Masaki Kato5,6, Takashi Tsuboi5,7, Norio Yasui-Furukori5,8, Atsuo Nakagawa5,9, Toshiaki Kikuchi5,9, Koichiro Watanabe5,7, Reiji Yoshimura1,5.   

Abstract

Purpose: To clarify the relationship between the length of unstable periods and employment status of patients with bipolar disorder. Patients and
Methods: Medical records of outpatients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics were investigated during September-October 2016, and details of their medical care and employment were surveyed using a questionnaire. The odds ratios (ORs) of length of unstable period and unemployment were analyzed with a logistic regression model.
Results: The study included 816 patients, of whom 707 were employed full-time (continuous employment) and 70 were unemployed (loss of employment). Univariate analysis showed that ORs were statistically significant for patients who were unstable for "almost all" of the year (OR = 10.4 [4.48-24.28] p < 0.001), but not for "few" unstable periods (OR = 1.06 [0.56-1.98] p = 0.849) and for "significant" unstable periods (OR = 1.65 [0.73-3.74] p = 0.231) were not significantly different. Multivariate analysis showed that ORs were statistically "significant" for patients who were unstable for "almost all" (OR = 12.1 [4.37-33.3] p < 0.001), but not for "few" unstable periods (OR = 1.07 [0.55-2.07] p = 0.846) and for "significant" unstable periods (OR = 1.62 [0.66-3.98] p = 0.290) did not differ significantly.
Conclusion: Patients with bipolar disorder with a long unstable period were associated with a higher risk of unemployment.
© 2022 Ikenouchi et al.

Entities:  

Keywords:  loss of employment; mood disorder; nationwide study; real world

Year:  2022        PMID: 35422623      PMCID: PMC9005072          DOI: 10.2147/NDT.S353460

Source DB:  PubMed          Journal:  Neuropsychiatr Dis Treat        ISSN: 1176-6328            Impact factor:   2.570


Introduction

Bipolar disorder is a chronic psychiatric disorder with both manic and depressive episodes that recur many times, often in one’s late teens or twenties.1 Bipolar I disorder is defined by the presence of symptomatic manic episodes, and the worldwide lifetime prevalence is estimated to be 0.6–1.0%. Bipolar II disorder, defined by the presence of symptomatic hypomanic and major depressive episodes, has a worldwide lifetime prevalence estimated at 0.4 to 1.1%.2 The lifetime prevalence of bipolar disorder in Japan has been estimated to range from 0.09% to 0.60%.2–4 Bipolar disorder results in a significant decline in daily functioning, including participation in work, social relationships, and the ability to live independently.5 The Global Burden of Disease Study showed that disability-adjusted life years (DALYs) become apparent in teenage years and peak in the twenties.6 A Danish study found that patients diagnosed with bipolar disorder were less likely to be employed with an odds ratio (OR) of 0.16.7 Three years before being diagnosed with bipolar disorder, 45% of the people with bipolar disorder were employed. However, this decreased to 34% five years after diagnosis.8 A survey of large Japanese companies revealed that the average number of sick days due to mental illnesses such as depression and bipolar disorder is approximately 120 days.9 A nationwide study in Sweden found that bipolar patients were 30% less likely to be able to work compared to the age-standardized population; of the 40% who were employed, 64% reported sick leave and 46% took more than 100 days/year.10 These results suggest that patients with bipolar disorder have low rates of employment, and those who are employed have high rates of sick leave. These employment problems affect both the individual and society. Bipolar disorder has significant direct and indirect costs. Miller et al reported that the estimated total costs due to bipolar disorder in the US in 2009 were $151 billion (direct costs: $30.7 billion; indirect costs: $120.3 billion).11 Since there are approximately 120,000 people with bipolar disorder in Japan, it is medically and socially important to develop supportive measures.12 The factors affecting the employment of patients with bipolar disorder are not well known. We previously reported a higher risk of unemployment during episodes of mania and depression compared to remission.13 Stability of the bipolar patients’ condition may be one of the factors associated with continued employment. The present study aimed to clarify the relationship between the duration of instability and employment status of patients with bipolar disorder.

Materials and Methods

Participants and Methods

A retrospective cohort investigation of the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) project was conducted at 1650 member clinics of the Japanese Association of Neuro-Psychiatric Clinics (JAPC).13–18 The JAPC member clinics treat about 30% of mood disorder patients in Japan.16 A total of 176 JAPC members took the survey in this study. All investigators at these clinics are psychiatrists, most of whom are either board certified by the Japanese Society of Psychiatry and Neurology or board certified by the Ministry of Health, Labor and Welfare. All medical records of patients with bipolar disorder who visited the 176 member clinics of the JAPC in September- October 2016 were investigated in September-December 2017. We gathered demographic information about the patients (age, sex, marital status, and occupational status), information about psychiatric and physical comorbidities, substance abuse, bipolar disorder subcategories, rapid cycling, psychotic symptoms, depressive symptoms, manic symptoms, suicidal ideation, details of pharmacological treatment, and unstable period at two intervals, October-December 2016 and October-December 2017. The diagnosis of bipolar disorder was based on the International Classification of Diseases and Related Health Problems, 10th edition (ICD-10). Clinical psychiatrists who participated in the survey completed the questionnaire through a retrospective medical record survey. The unstable period was defined as the time when some psychiatric symptoms were strong or when daily functioning was impaired. The unstable period was defined as “few” if it was between 1–33% of the year, “significant” if it was between 34–66%, and “almost all” if it was between 67–100%. Regarding employment status, we defined full-time workers as those who worked 30 hours or more per week. We defined “continuous employment” as those who were working full time in 2016 (our baseline year) and were still working full time in 2017 (one year later), and “loss of employment” as those who were working full-time in 2016 and were unemployed one year later.

Ethics

This study was conducted in accordance with the principles of the Declaration of Helsinki and the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects. Before the initiation of the study, the study protocol was reviewed and approved by the institutional review board of the ethics committee of the Japanese Association of Neuro-Psychiatric Clinics and the University of Occupational and Environmental Health, Japan. These ethics committees also exempted us from obtaining informed consent because this study is a retrospective medical record survey. Instead, we published information about this study to give patients the freedom to opt-out. To protect patients’ personal information, we assigned each patient an arbitrary identification number for this study.

Statistical Analysis

In the univariate analysis, we performed a logistic regression between unstable period and continuous employment. To avoid confounding effects of each factor, multivariate logistic regression analysis was then conducted. The multivariate logistic regression analysis used employment status as the dependent variable. We analyzed the OR of unstable period to employment status (few: 1–33%, significant: 34–66%, almost all: 67–100%) using a logistic regression model. Details of all the above patients were included in this model as confounding adjustment factors. The level of probability was set at 5%. The analysis was performed using Stata SE/17 (Stata Corp LLC, College Station, TX, USA).

Results

As the baseline, questionnaires returned from 176 clinics for 3137 outpatients with bipolar disorder, of whom 3081 provided their occupation, were used. Among the 3081 patients, 2292 were aged < 60 years, of which 997 (43.5%) were full-time workers. A follow-up study was conducted one year later on these 968 patients who were full-time workers aged < 59 years. Finally, the study included 816 patients (84.3%), of whom 707 were employed full-time (continuous employment) and 70 were unemployed (loss of employment). Data of the patients in the continuous and loss of employment groups are presented in Table 1. Although the age and bipolar subcategories were relatively similar between the two groups, there were differences in other attributes, symptoms, and treatment.
Table 1

Clinical Characteristics of Patients with Continuous Employment and Loss of Employment

Continuous EmploymentLoss of Employment
Number70770
Sex men485 (69%)23 (33%)
Age (SD)44.4 (8.7)42.9 (10.1)
Marital status
 Married389 (56%)30 (44%)
 Separated/widowed84 (12%)7 (10%)
 Unmarried220 (32%)31 (46%)
Psychiatric comorbidity117 (17%)12 (17%)
Physical comorbidity180 (25%)13 (19%)
Substance abuse51 (6%)1 (1%)
Bipolar disorder subcategories
 Type I179 (25%)17 (24%)
 Type II448 (69%)48 (69%)
 Unclassifiable39 (6%)5 (7%)
Rapid cycling62 (9%)4 (6%)
Psychotic symptoms35 (5%)7 (10%)
Depressive symptoms294 (42%)39 (56%)
Manic symptoms96 (14%)15 (21%)
Suicide ideation45 (6%)8 (11%)
Number of mood stabilizer prescriptions
 0110 (16%)15 (21%)
 1 or more598 (84%)55 (79%)
Number of antipsychotic prescriptions
 0376 (53%)33 (47%)
 1 or more332 (47%)37 (53%)
Number of antidepressant prescriptions
 0402 (57%)37 (53%)
 1 or more305 (43%)33 (47%)
Unstable periods
 None (0%)281 (40%)20 (29%)
 Few (1–33%)310 (44%)25 (36%)
 Significant (34–66%)92 (13%)10 (14%)
 Almost all (67–100%)24 (3%)15 (21%)

Abbreviation: SD, standard division.

Clinical Characteristics of Patients with Continuous Employment and Loss of Employment Abbreviation: SD, standard division. The findings of the univariate and multivariate analyses are shown in Table 2. The univariate analysis showed that the OR for unemployment was statistically significant for those who were unstable for “almost all” of the year, ie, those who spent 67–100% of the year in an unstable (OR = 10.4 [4.48–24.28] p < 0.001) state of mind. However, no significant differences were found for those who had “few” unstable periods (OR = 1.06 [0.56–1.98] p = 0.849) or “significant” periods of instability (OR = 1.65 [0.73–3.74] p = 0.231). The multivariate analysis showed that the OR for unemployment was statistically significant for those who had “almost all” unstable periods (OR = 12.1 [4.37–33.31] p < 0.001). No significant difference was noted for “few” unstable periods (OR = 1.07 [0.55–2.07] p = 0.846) and “significant” unstable periods (OR = 1.62 [0.66–3.98] p = 0.290).
Table 2

Association Between Unstable Periods and Continuous Employment

Unstable PeriodUnivariableMultivariable*
Odds Ratio95% Conf Intervalp valueOdds Ratio95% Conf Intervalp value
None (0%)ReferenceReference
Few (1~33%)1.060.561.980.8491.070.552.070.846
Significant (34~66%)1.650.733.740.2311.620.663.980.290
Almost all (67~100%)10.44.4824.28<0.00112.14.3733.31<0.001

Notes: *The multivariate model adjusted for age, sex, marital status, psychiatric comorbidity, physical comorbidity, substance abuse, bipolar disorder subcategories, rapid cycling, psychotic symptoms, depressive symptoms, manic symptoms, suicide ideation, number of mood stabilizer prescriptions, number of antipsychotic prescriptions, and number of antidepressant prescriptions.

Association Between Unstable Periods and Continuous Employment Notes: *The multivariate model adjusted for age, sex, marital status, psychiatric comorbidity, physical comorbidity, substance abuse, bipolar disorder subcategories, rapid cycling, psychotic symptoms, depressive symptoms, manic symptoms, suicide ideation, number of mood stabilizer prescriptions, number of antipsychotic prescriptions, and number of antidepressant prescriptions. The multivariate analysis showed no significant differences for physical complications (OR = 0.48 [0.23–1.02] p = 0.055), substance abuse (OR = 0.15 [0.15–1.58] p = 0.115), and rapid cycling (OR = 0.39 [0.07–2.03] p = 0.262). Significant differences were noted for women (OR=4.60 [2.51–8.42] p < 0.001) as compared to men.

Discussion

This study was conducted to investigate the impact of unstable periods on continued employment in patients with bipolar disorder. In this nationwide multicenter study, we investigated the employment status of patients with bipolar disorder in Japan from 2016 to 2017. The findings suggested that the employment rate of patients with bipolar disorder was 43.5%. Studies published overseas have reported that the employment rate of bipolar patients is 40–60%, which is similar to the results of this study.8,19,20 Among those who were employed, patients with bipolar disorder who were unstable for more than two-thirds of the time had 12.1 times higher risk of loss of employment in the multivariate analysis compared to those who were stable. In contrast, patients with bipolar disorder who were unstable for less than two-thirds of the time did not have an increased risk of unemployment. In other words, patients with mild to moderate mood instability can sustain employment. The reason for the drastic increase in the OR over the border is unknown. Previous reports indicate that two-thirds of employed patients with bipolar disorder take sick leave, and half of these patients take more than 100 days of leave per year.10 Bipolar disorder results in impaired cognitive and occupational functioning, which leads to poor workplace performance and reduced job functioning.21–23 Factors associated with poor occupational and functional outcomes in bipolar disorder include the number of affective episodes,24 severity of total symptoms,25 subclinical depressive symptoms,26 history of psychotic symptoms,27 history of psychiatric hospitalization,8,25,28 comorbid psychiatric disorders,24,29 substance abuse,8,24 age,8 and age of onset.29,30 We also reported that patients with depressive or manic episodes have a higher risk of unemployment than those in remission.13 It has been reported that the primary factor associated with occupational dysfunction in patients with bipolar disorder is impairment in executive functioning, rather than other important clinical factors such as general cognitive functioning (IQ) or severity of illness.31 Kato et al reported that patients with bipolar disorder employed in Japan had significantly higher activity impairment, presenteeism, and lower work productivity, resulting in greater indirect costs, and total indirect costs were higher for patients with bipolar disorder than for those with major depressive disorder, and even higher for patients with severe depressive symptoms.3 Environmental factors such as support systems for the patients in the company and their family members might influence the continuation of employment.8,25 In Japan, employees can take sick leave, and this period can vary from a few months to several years, depending on the workplace. Typically, no salary is paid during this period, but the health insurance association will provide an injury and illness allowance for one year and six months. This is available to all workers, but some companies offer more generous coverage. These leave programs vary among countries, so these results may not be generalizable to countries outside Japan. In this study, the incidence of psychotic symptoms and suicidal ideation was lower in the continuous employment group than in loss of employment group, but there was no difference in the incidence of psychological comorbidities. Meanwhile, the incidence of physical comorbidity, substance abuse, and rapid cycling was higher among the continuously employed group than among the unemployed group in this study. Some unmeasured biases may have influenced these results. The rate of continued employment was higher for men with bipolar disorder than for women with the same disorder. This difference is consistent with the findings of several studies.32,33 One possible reason for this gender difference is that women with bipolar disorder often spend more time in a depressed state and have more rapid changes in their condition than men.32,33 Depressive symptoms and faster illness cycle lapse are both associated with decreased employability.25,34,35 In addition, a survey by the Ministry of Health, Labor and Welfare (2019) reported that the turnover rate of full-time workers in Japan in 2019 was 13.4% for men and 18.2% for women.36 Therefore, this result may be influenced by social gender differences in Japan. Previous studies have reported that among patients with bipolar disorder, being unemployed is associated with poorer cognitive and social functioning, higher depressive symptoms, and lower educational qualification.25,34,37–39 Conversely, longitudinal qualitative studies show that people with bipolar disorder who obtain employment often experience a significant improvement in their living conditions.40,41 The likelihood of future psychiatric hospitalization is reduced when unemployed people with severe mental illness find employment, especially when employment is maintained for more than six months.42 Clinicians should support patients in maintaining employment, not only because working is a valuable outcome in and of itself, but also because working leads to fewer hospitalizations. The strength of this study is that it is a real-world study using data from a multi-institutional setting that treats the majority of the patients with mood disorders in Japan. However, the current study also has several limitations. First, the risk of long-term unemployment is unknown because the present study only included a one-year retrospective follow-up. Considering the course of bipolar disorder, a longer study is desirable, including a survey of those who have started working. Second, the follow-up rate after one year was relatively good at 84.3%, but the effect of dropouts was unknown. Third, since our study focused on the relationship between symptom instability and unemployment over a one-year period, the modifying effects of treatment and detailed comorbidities are unknown. In particular, the impact of treatment is unknown because they are clinically controlled by the patient’s primary care physician. In this study, medications and other treatments were considered, but adherence was unknown, and non-pharmacological treatments such as psychotherapy were not considered. Fourth, although the study was conducted by well-trained physicians, it was conducted concurrently with routine clinical care, and thus was assessed in a single interview and no structured clinical interview was conducted, which may have resulted in rater variability. Fifth, we did not assess baseline functioning and did not use a rating scale, which may have reduced the accuracy of the assessment.

Conclusion

The MUSUBI Study found that 43.5% of patients with bipolar disorder receiving outpatient treatment were full-time workers. Assessment of stability by a well-trained physician predicts the risk of unemployment; patients with bipolar disorder whose condition is unstable most of the time are at a high risk of unemployment. In order for patients with bipolar disorder to continue working, there is a need for support which will increase the period of stability.

Abbreviations

DALYs, disability-adjusted life years; OR, odds ratio; MUSUBI, Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics; JPAC, Japanese Association of Neuro-Psychiatric Clinics; ICD-10, International Classification of Diseases and Related Health Problems, 10th edition.
  40 in total

1.  A ten-year follow-up of a supported employment program.

Authors:  Michelle P Salyers; Deborah R Becker; Robert E Drake; William C Torrey; Philip F Wyzik
Journal:  Psychiatr Serv       Date:  2004-03       Impact factor: 3.084

2.  Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM).

Authors:  C Reed; I Goetz; E Vieta; M Bassi; J M Haro
Journal:  Eur Psychiatry       Date:  2010-10       Impact factor: 5.361

Review 3.  Prevalence of mental disorders and mental health service use in Japan.

Authors:  Daisuke Nishi; Hanako Ishikawa; Norito Kawakami
Journal:  Psychiatry Clin Neurosci       Date:  2019-06-18       Impact factor: 5.188

Review 4.  The prevalence and burden of bipolar depression.

Authors:  Shefali Miller; Bernardo Dell'Osso; Terence A Ketter
Journal:  J Affect Disord       Date:  2014-12       Impact factor: 4.839

5.  Influence of birth cohort on age of onset cluster analysis in bipolar I disorder.

Authors:  M Bauer; T Glenn; M Alda; O A Andreassen; E Angelopoulos; R Ardau; C Baethge; R Bauer; F Bellivier; R H Belmaker; M Berk; T D Bjella; L Bossini; Y Bersudsky; E Y W Cheung; J Conell; M Del Zompo; S Dodd; B Etain; A Fagiolini; M A Frye; K N Fountoulakis; J Garneau-Fournier; A Gonzalez-Pinto; H Harima; S Hassel; C Henry; A Iacovides; E T Isometsä; F Kapczinski; S Kliwicki; B König; R Krogh; M Kunz; B Lafer; E R Larsen; U Lewitzka; C Lopez-Jaramillo; G MacQueen; M Manchia; W Marsh; M Martinez-Cengotitabengoa; I Melle; S Monteith; G Morken; R Munoz; F G Nery; C O'Donovan; Y Osher; A Pfennig; D Quiroz; R Ramesar; N Rasgon; A Reif; P Ritter; J K Rybakowski; K Sagduyu; A M Scippa; E Severus; C Simhandl; D J Stein; S Strejilevich; A Hatim Sulaiman; K Suominen; H Tagata; Y Tatebayashi; C Torrent; E Vieta; B Viswanath; M J Wanchoo; M Zetin; P C Whybrow
Journal:  Eur Psychiatry       Date:  2014-12-12       Impact factor: 5.361

6.  Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study.

Authors:  Andreas Carlborg; Lena Ferntoft; Marcus Thuresson; Johan Bodegard
Journal:  Bipolar Disord       Date:  2014-07-24       Impact factor: 6.744

7.  Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI).

Authors:  Masaki Kato; Naoto Adachi; Yukihisa Kubota; Takaharu Azekawa; Hitoshi Ueda; Kouji Edagawa; Eiichi Katsumoto; Eiichiro Goto; Seiji Hongo; Takashi Tsuboi; Norio Yasui-Furukori; Reiji Yoshimura; Atsuo Nakagawa; Toshiaki Kikuchi; Toshihiko Kinoshita; Youichiro Watanabe; Kazuhira Miki; Koichiro Watanabe
Journal:  J Psychiatr Res       Date:  2020-09-30       Impact factor: 4.791

8.  Severity of mood symptoms and work productivity in people treated for bipolar disorder.

Authors:  Gregory E Simon; Evette J Ludman; Jürgen Unützer; Belinda H Operskalski; Mark S Bauer
Journal:  Bipolar Disord       Date:  2008-09       Impact factor: 6.744

9.  Association between cognitive functioning and employment status of persons with bipolar disorder.

Authors:  Faith B Dickerson; John J Boronow; Cassie R Stallings; Andrea E Origoni; Sara Cole; Robert H Yolken
Journal:  Psychiatr Serv       Date:  2004-01       Impact factor: 3.084

Review 10.  The Relationship Between Neurocognitive Functioning and Occupational Functioning in Bipolar Disorder: A Literature Review.

Authors:  Walace Duarte; Rodrigo Becerra; Kate Cruise
Journal:  Eur J Psychol       Date:  2016-11-18
View more
  1 in total

1.  Effect of age and sex on prescriptions for outpatients with bipolar disorder in the MUSUBI study: a cross‑sectional study.

Authors:  Yasushi Kawamata; Norio Yasui-Furukori; Naoto Adachi; Hitoshi Ueda; Seiji Hongo; Takaharu Azekawa; Yukihisa Kubota; Eiichi Katsumoto; Koji Edagawa; Eiichiro Goto; Kazuhira Miki; Masaki Kato; Atsuo Nakagawa; Toshiaki Kikuchi; Takashi Tsuboi; Reiji Yoshimura; Kazutaka Shimoda; Koichiro Watanabe
Journal:  Ann Gen Psychiatry       Date:  2022-09-12       Impact factor: 3.301

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.